Standout Papers

Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocell... 2017 2026 2020 2023 322
  1. Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial (2017)
    Tim Meyer, Richard Fox et al. ˜The œLancet. Gastroenterology & hepatology

Immediate Impact

3 by Nobel laureates 2 from Science/Nature 104 standout
Sub-graph 1 of 17

Citing Papers

EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
2024 Standout
14 intermediate papers

Works of Yuk Ting being referenced

TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial
2020
Prognostic scores for sorafenib-treated hepatocellular carcinoma patients: A new application for the hepatoma arterial embolisation prognostic score
2017
and 5 more

Author Peers

Author Last Decade Papers Cites
Yuk Ting 416 563 325 64 1.1k
Lie Zheng 370 551 381 70 1.2k
Takeshi Nagao 239 640 415 61 1.3k
Masayoshi Yoshimori 447 397 403 41 1.1k
Xinyu Bi 462 378 303 98 1.1k
Ningling Ge 496 682 268 42 1.4k
Andrea Gardini 429 655 527 40 1.3k
Stacey Stein 780 342 253 74 1.4k
Roopinder Gillmore 670 361 317 48 1.3k
Lujun Shen 391 358 223 91 1.1k
Yukio Iwashita 520 466 496 77 1.3k

All Works

Loading papers...

Rankless by CCL
2026